MetLife Investment Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.4K | Buy |
26,831
+5,919
| +28% | +$18.4K | ﹤0.01% | 2630 |
|
|
2025
Q1 | $70.7K | Sell |
20,912
-6,123
| -23% | -$20.7K | ﹤0.01% | 2644 |
|
|
2024
Q4 | $153K | Hold |
27,035
| – | – | ﹤0.01% | 2430 |
|
|
2024
Q3 | $158K | Hold |
27,035
| – | – | ﹤0.01% | 2409 |
|
|
2024
Q2 | $214K | Buy |
27,035
+8,766
| +48% | +$69.3K | ﹤0.01% | 2201 |
|
|
2024
Q1 | $170K | Buy |
18,269
+1,448
| +9% | +$13.5K | ﹤0.01% | 2284 |
|
|
2023
Q4 | $142K | Hold |
16,821
| – | – | ﹤0.01% | 2423 |
|
|
2023
Q3 | $130K | Hold |
16,821
| – | – | ﹤0.01% | 2451 |
|
|
2023
Q2 | $193K | Buy |
+16,821
| New | +$193K | ﹤0.01% | 2294 |
|
|
2020
Q4 | – | Sell |
-10,649
| Closed | -$114K | – | 2316 |
|
|
2020
Q3 | $114K | Hold |
10,649
| – | – | ﹤0.01% | 2161 |
|
|
2020
Q2 | $134K | Hold |
10,649
| – | – | ﹤0.01% | 2114 |
|
|
2020
Q1 | $97.4K | Hold |
10,649
| – | – | ﹤0.01% | 2094 |
|
|
2019
Q4 | $149K | Hold |
10,649
| – | – | ﹤0.01% | 2137 |
|
|
2019
Q3 | $183K | Hold |
10,649
| – | – | ﹤0.01% | 2001 |
|
|
2019
Q2 | $290K | Hold |
10,649
| – | – | ﹤0.01% | 1807 |
|
|
2019
Q1 | $204K | Hold |
10,649
| – | – | ﹤0.01% | 1974 |
|
|
2018
Q4 | $100K | Hold |
10,649
| – | – | ﹤0.01% | 2301 |
|
|
2018
Q3 | $201K | Hold |
10,649
| – | – | ﹤0.01% | 2077 |
|
|
2018
Q2 | $208K | Buy |
10,649
+2,964
| +39% | +$57.9K | ﹤0.01% | 1903 |
|
|
2018
Q1 | $144K | Hold |
7,685
| – | – | ﹤0.01% | 2055 |
|
|
2017
Q4 | $128K | Buy |
+7,685
| New | +$128K | ﹤0.01% | 2146 |
|